Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Personalized neurostimulation for Tourette's Syndrome

Official title: Investigating the Effect of Responsive Neurostimulation (RNS) in Patients with Treatment-refractory Tourette's Syndrome (TR-TS)

Run by Xuanwu Hospital, Beijing · NCT06785532 · Data updated 2026-11-12

This study is testing a personalized brain stimulation treatment for adults with Tourette's Syndrome who haven't found relief from other therapies to see if it can help reduce their severe tics.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment10 (estimated)
SponsorXuanwu Hospital, Beijing
Academic / other
Locations1 site (Beijing)
StatusRecruiting
StartedFebruary 5, 2025
Main results expectedDecember 31, 2028
Study endsDecember 31, 2029
Registry record updatedJanuary 21, 2025
Trial IDNCT06785532 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18-65 with a confirmed diagnosis of Tourette's Syndrome who have not responded to standard treatments.

Probably not a fit

Patients with other psychotic disorders or those who have undergone certain neuromodulation therapies may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of personalized responsive neurostimulation (RNS) therapy in patients with treatment-resistant Tourette's Syndrome (TR-TS). It utilizes stereoelectroencephalography (SEEG) to identify individualized stimulation targets in the brain, aiming to alleviate severe tics that have not responded to conventional treatments. The study focuses on patients aged 18-65 who have experienced significant symptoms for at least 12 months and have failed multiple medication classes. By mapping neuronal activity in specific brain regions, the study seeks to provide a tailored approach to managing TR-TS.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the severity of tics in patients with treatment-resistant Tourette's Syndrome.

How similar studies have gone: While there is limited high-quality evidence for RNS in Tourette's Syndrome, similar neuromodulation approaches have shown promise in other conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. aged 18-65;
2. able to provide written informed consent;
3. have a diagnosis of Tourette's syndrome according to the Statistical Manual of Mental Disorders-Fourth Edition-Text Revised (DSM-IV-TR) criteria and confirmed by the Mini-International Neuropsychiatric Interview Chinese version 5.0;
4. with a YGTSS of at least 35 for at least 12 months before surgery, while YGTSS- Total Motor≥15;
5. must have failed conventional medical treatment at adequate therapeutic doses of three classes of medication lasting for at least three months;
6. must not be suitable for behavioural intervention or that this intervention is inappropriate or unsuccessful;
7. have been on stable comorbid conditions without suicidal ideation for at least six months.

Exclusion Criteria:

1. presence of other psychotic disorders;
2. have a treatment history that includes electroconvulsive therapy (ECT), modified electroconvulsive therapy (MECT), transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), DBS, and transcranial magnetic stimulation (TMS);
3. presents a suicide risk (defined as a HAMD-17 score of ≥3 on suicide-related items);
4. experience difficulty in effectively communicating with investigators;
5. with a history of traumatic brain injury (TBI);
6. with intracranial or cardiovascular stents;
7. substance abuse within the past six months;
8. unstable neurological or coagulation disorders;
9. women who are pregnant, lactating, or of childbearing potential who refuse the use of reliable contraception during the study;
10. have been involved in other clinical studies within three months before enrollment in this study;
11. any conditions considered by the study group.

Where it's running

  • Xuanwu Hospital, Capital Medical University
    Beijing, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.